SCHEMBL9701376

SCHEMBL9701376

Cc1cc(Cl)c2c(c1)Nc1c(c(=O)[nH][nH]c1=O)C2

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 1/20 0.34
BRD4 O60885 1/20 0.30
CREBBP Q92793 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7478045 0.86 CES1 (0.40) PDE7A
SCHEMBL10130338 0.77 AHR (0.44) PDE7A
SCHEMBL7485832 0.69 AHR (0.60) PDE7A
SCHEMBL7976982 0.68 CES1 (0.35)
SCHEMBL10130809 0.62 PARP1 (0.42) BRD4CREBBP
SCHEMBL20278370 0.61 PDE3B (0.55)
SCHEMBL6411297 0.60 AHR (0.53) PDE7A
SCHEMBL5378136 0.59 CA12 (0.40) BRD4CREBBP
SCHEMBL8573750 0.58 CES1 (0.69) PDE7A
SCHEMBL23408301 0.57 AHR (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0516297-A1 Pyridazinediones and their use in the treatment of neurological disorders ZENECA LIMITED (GB) 1992-12-02 EP claimed